ADK
adenosine kinase
ADK; adenosine kinase; adenosine 5 phosphotransferase; AK; 5033405D03Rik; AI255373; AI987814; MGC6593; 2310026J05Rik; ADK_HUMAN; OTTHUMP00000019864; OTTHUMP00000019865; adenosine 5-phosphotransferase;
AKT1S1
AKT1 substrate 1 (proline-rich)
AKT1S1; AKT1 substrate 1 (proline-rich); Lobe; PRAS40; proline-rich AKT1 substrate 1; 40 kDa proline-rich AKT substrate; proline-rich Akt substrate, 40 kDa; OTTHUMP00000196757; PRAS40; OTTHUMP00000196758; Lobe; OTTHUMP00000196759; MGC2865; OTTHUMP00000196760; OTTHUMP00000196756; proline-rich Akt substrate of 40 kDa;
AKT2
v-akt murine thymoma viral oncogene homolog 2
Akt2; AKT2_HUMAN; PKB; PKB beta; PKBBETA; PRKBBy; Protein kinase Akt 2; Protein kinase Akt-2; Protein kinase B beta; RAC BETA; RAC beta serine threonine protein kinase; RAC PK beta; Rac protein kinase beta; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; RACbeta; V AKT Murine Thymoma Viral Oncogene Homolog 2;
AKT3
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma); PKBG; PRKBG; STK-2; PKB-GAMMA; RAC-gamma; RAC-PK-gamma; DKFZp434N0250; RAC-gamma serine/threonine-protein kinase; PKB gamma; OTTHUMP00000037911; OTTHUMP00000037912; protein kinase Akt-3; protein kinase B gamma; serine threonine protein kinase, Akt-3;
BCR
breakpoint cluster region
BCR; breakpoint cluster region; BCR1, D22S11; breakpoint cluster region protein; ALL; CML; D22S662; PHL; renal carcinoma antigen NY-REN-26; BCR1; D22S11; FLJ16453;
JAK2
JAK2 Janus kinase 2
JAK2; Janus kinase 2; tyrosine-protein kinase JAK2; JTK10; JAK-2; Janus kinase 2 (a protein tyrosine kinase); THCYT3;
NUAK1
NUAK family, SNF1-like kinase, 1
NUAK1; NUAK family, SNF1-like kinase, 1; NUAK family SNF1-like kinase 1; AMP activated protein kinase family member 5; ARK5; KIAA0537; omphalocele kinase 1; AMPK-related protein kinase 5; AMP-activated protein kinase family member 5;
NUAK2
NUAK family, SNF1-like kinase, 2
NUAK2; NUAK family, SNF1-like kinase, 2; NUAK family SNF1-like kinase 2; FLJ90349; SNARK; SNF1/AMP activated protein kinase; DKFZp434J037; DKFZp686F01113; NUAK family SNF1 like kinase 2; NUAK2_HUMAN; SNF1/AMP kinase related kinase; SNF1/AMP kinase-related kinase; omphalocele kinase 2;
PTPN4
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)
PTPN4; protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte); MEG; PTPMEG; PTPMEG1; tyrosine-protein phosphatase non-receptor type 4; PTPase-MEG1; megakaryocyte phosphatase; protein tyrosine phosphatase MEG1; protein-tyrosine phosphatase MEG1; megakaryocyte protein-tyrosine phosphatase;
SSX4
synovial sarcoma, X breakpoint 4
SSX4; synovial sarcoma, X breakpoint 4; protein SSX4; CT5.4; MGC12411; Synovial sarcoma X breakpoint 4; OTTHUMP00000024292; OTTHUMP00000216158; cancer/testis antigen 5.4; SSX4B;
UPK3A
uroplakin 3A
UPK3A; uroplakin 3A; UPK3, uroplakin 3; uroplakin-3a; uroplakin III; UP3A; UPK3; UPIII; UPIIIA; MGC119178;
XRCC5
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
XRCC5; X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining); X ray repair complementing defective repair in Chinese hamster cells 5 (double strand break rejoining; Ku autoantigen, 80kD); X-ray repair cross-complementing protein 5; KARP 1; Ku autoantigen; 80kDa; KU80; Ku86; KUB2; TLAA; CTC85; CTCBF; nuclear factor IV; Ku autoantigen, 80kDa; DNA repair protein XRCC5; thyroid-lupus autoantigen; 86 kDa subunit of Ku antigen; lupus Ku autoantigen protein p86; Ku86 autoantigen related protein 1; CTC box-binding factor 85 kDa subunit; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; NFIV; KARP1; KARP-1; FLJ39089;
IP6K2
Inositol Hexakisphosphate Kinase 2
PIUS; IHPK2; IP6K2; inositol hexakisphosphate kinase 2; insp6 kinase 2; OTTHUMP00000164824; OTTHUMP00000210210; OTTHUMP00000210211; OTTHUMP00000210215; OTTHUMP00000210229; OTTHUMP00000210234; pi uptake stimulator; inositol hexaphosphate kinase 2; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase;
AHNAK
AHNAK nucleoprotein
AHNAK; AHNAK nucleoprotein; AHNAK nucleoprotein (desmoyokin); neuroblast differentiation-associated protein AHNAK; desmoyokin; AHNAK-related; MGC5395; PM227; AHNAKRS; OTTHUMP00000236155; OTTHUMP00000236448; OTTHUMP00000236450; OTTHUMP00000236451; Desmoyokin;
AKTIP
AKT interacting protein
AKTIP; AKT interacting protein; FTS, fused toes (mouse) homolog , fused toes homolog (mouse); AKT-interacting protein; FLJ13258; AKTIP_HUMAN; FT 1; FT1; Fused toes homolog; Fused toes protein homolog; OTTHUMP00000164256; FTS;
CTNND2
catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)
CTNND2; catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein); catenin delta-2; GT24; NPRAP; Catenin (cadherin associated protein) delta 2; Catenin delta 2; CTND2_HUMAN; CTNND 2; Delta catenin; Delta-catenin; GT 24; Neural plakophilin related arm repeat protein; Neural plakophilin related armadillo repeat protein; Neural plakophilin-related ARM-repeat protein; Neurojungin; OTTHUMP00000115594; OTTHUMP00000220687; OTTHUMP00000220689; OTTHUMP00000220690; T-cell delta-catenin;
EWSR1
Ewing sarcoma breakpoint region 1
EWSR1; Ewing sarcoma breakpoint region 1; RNA-binding protein EWS; EWS; Ewings sarcoma EWS-Fli1 (type 1) oncogene; bK984G1.4;
ITPK1
inositol-tetrakisphosphate 1-kinase
ITPK1; inositol-tetrakisphosphate 1-kinase; inositol 1,3,4 triphosphate 5/6 kinase; ins(1,3,4)P(3) 5/6-kinase; inositol-triphosphate 5/6-kinase; inositol 1,3,4-triphosphate 5/6 kinase; inositol 1,3,4-trisphosphate 5/6 kinase; inositol 1,3,4-trisphosphate;
JTB
jumping translocation breakpoint
JTB; jumping translocation breakpoint; protein JTB; hJT; prostate androgen regulated gene; HJTB; HSPC222; JTB_HUMAN; Jumping translocation breakpoint protein; OTTHUMP00000034759; PAR; PAR protein; Prostate androgen regulated protein; Prostate androgen-regulated protein;
JUP
junction plakoglobin
JUP; junction plakoglobin; catenin (cadherin associated protein), gamma 80kDa , CTNNG; DP3; DPIII; PDGB; PKGB; catenin gamma; desmoplakin-3; gamma-catenin; desmoplakin III; catenin (cadherin-associated protein), gamma 80kDa; catenin (cadherin-associated p;
KCNA3
potassium voltage-gated channel, shaker-related subfamily, member 3
KCNA3; potassium voltage-gated channel, shaker-related subfamily, member 3; potassium voltage-gated channel subfamily A member 3; HLK3; HPCN3; Kv1.3; MK3; potassium channel 3; type n potassium channel; voltage-gated K(+) channel HuKIII; voltage-gated potassium channel protein Kv1.3; voltage-gated potassium channel subunit Kv1.3; HGK5; PCN3; HUKIII;
MATK
megakaryocyte-associated tyrosine kinase
MATK; megakaryocyte-associated tyrosine kinase; megakaryocyte-associated tyrosine-protein kinase; CHK; Csk homologous kinase; Csk type protein tyrosine kinase; CTK; DKFZp434N1212; hematopoietic consensus tyrosine lacking kinase; HHYLTK; hydroxyaryl protein kinase; HYL; HYL tyrosine kinase; HYLTK; leukocyte carboxyl terminal src kinase relat; EC 2.7.10.2; Leukocyte carboxyl terminal src kinase related; Lsk; Megakaryocyte associated tyrosine kinase; Megakaryocyte associated tyrosine protein kinase; MGC1708; MGC2101; Protein kinase HYL; Tyrosine kinase MATK; Tyrosine protein kinase CTK; Tyrosylprotein kinase; Csk-homologous kinase; hydroxyaryl-protein kinase; tyrosine-protein kinase CTK; Csk-type protein tyrosine kinase; leukocyte carb;
MKRN2
makorin ring finger protein 2
MKRN2; makorin ring finger protein 2; probable E3 ubiquitin-protein ligase makorin-2; HSPC070; RNF62; Makorin 2; Makorin2; MKRN 2; RING finger protein 62; RNF 62;
PKP4
Plakophilin 4
PKP4; plakophilin 4; p0071; Plakophilin-4; catenin 4; FLJ31261; FLJ42243; OTTHUMP00000204742; OTTHUMP00000204743;
UPK1B
uroplakin 1B
UPK1B; uroplakin 1B; UPK1; uroplakin-1b; TSPAN20; Tetraspanin-20; Tspan-20; UP1b; UPIb; UPK1B_HUMAN; Uroplakin Ib; tetraspan; OTTHUMP00000215018; OTTHUMP00000215019; OTTHUMP00000215020; OTTHUMP00000215021; OTTHUMP00000215022;
SSX1
synovial sarcoma, X breakpoint 1
SSX1; synovial sarcoma, X breakpoint 1; protein SSX1; cancer/testis antigen family 5; member 1; CT5.1; X breakpoint 1; Cancer/testis antigen 5.1; Cancer/testis antigen family 5 member 1; MGC150425; MGC5162; sarcoma, synovial, X chromosome related 1; SSRC; SSX1_HUMAN; Synovial sarcoma; cancer/testis antigen family 5, member 1; sarcoma, synovial, X-chromosome-related 1;
SSX2
synovial sarcoma, X breakpoint 2
SSX2; synovial sarcoma, X breakpoint 2; SSX; protein SSX2; cancer/testis antigen family 5; member 2a; CT5.2a; HD21; HOM MEL 40; MGC3884; MGC15364; MGC119055; sarcoma; synovial; X chromosome related 2; synovial sarcoma; X breakpoint 2; isoform b; X breakpo;
FCN3
ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)
FCN3; ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen); ficolin-3; FCNH; HAKA1; Collagen/fibrinogen domain containing lectin 3 p35; Collagen/fibrinogen domain containing protein 3; FCN 3; Ficolin (collagen/fibrinogen domain containing) 3; Ficolin 3; H ficolin; Hakata antigen; MGC22543; H-ficolin; OTTHUMP00000006338; OTTHUMP00000006339; collagen/fibrinogen domain-containing protein 3; collagen/fibrinogen domain-containing lectin 3 p35;
KCNA1
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
KCNA1; potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia); EA1; MK1; AEMK; HBK1; HUK1; MBK1; RBK1; KV1.1; potassium voltage-gated channel subfamily A member 1; voltage-gated K(+) channel HuKI; voltage-gated potassium channel HBK1; voltage-gated potassium channel subunit Kv1.1;
MKRN1
makorin ring finger protein 1
MKRN1; makorin ring finger protein 1; E3 ubiquitin-protein ligase makorin-1; RNF61; RING finger protein 61; FLJ21334;
MKRN3
makorin ring finger protein 3
MKRN3;makorin ring finger protein 3;D15S9, ZNF127;probable E3 ubiquitin-protein ligase makorin-3;MGC88288;RNF63;ZFP127;zinc finger protein 127;RING finger protein 63;D15S9;ZNF127;
SFRS17A
AKAP17A A kinase (PRKA) anchor protein 17A
XE7; 721P; XE7Y; CCDC133; CXYorf3; PRKA17A; SFRS17A; AKAP-17A; DXYS155E; FLJ98315; MGC39904; MGC125365; MGC125366; A-kinase anchor protein 17A; OTTHUMP00000022831; OTTHUMP00000022832; OTTHUMP00000022833; pseudoautosomal gene XE7; B-lymphocyte surface antigen; protein kinase A-anchoring protein 17A; splicing factor, arginine/serine-rich 17A;
SSX3
synovial sarcoma, X breakpoint 3
SSX3; synovial sarcoma, X breakpoint 3; protein SSX3; CT5.3; MGC119054; Cancer/testis antigen 5.3; MGC14495; SSX3_HUMAN; synovial sarcoma, X breakpoint 3, isoform a;
ICK
intestinal cell (MAK-like) kinase
ICK; intestinal cell (MAK-like) kinase; serine/threonine-protein kinase ICK; KIAA0936; LCK2; MGC46090; MRK; hICK; MAK-related kinase; laryngeal cancer kinase 2; serine/threonine protein kinase; ECO;
AHNAK2
AHNAK nucleoprotein 2
AHNAK2; AHNAK nucleoprotein 2; C14orf78, chromosome 14 open reading frame 78; protein AHNAK2; C14orf78; AHNAK 2; chromosome 14 open reading frame 78; KIAA2019;
AKIRIN2
akirin 2
AKIRIN2; akirin 2; C6orf166, chromosome 6 open reading frame 166; akirin-2; dJ486L4.2; FLJ10342; AKIR2_HUMAN; C6orf166; FBI1; Fourteen three three beta interactant 1; OTTHUMP00000016836; fourteen-three-three beta interactant 1;
C11orf17
AKIP1 A kinase (PRKA) interacting protein 1
chromosome 11 open reading frame 17; koyt binding protein 1; AKIP1; koyt binding protein 2; BCA3; koyt binding protein 3; Breast cancer-associated gene 3 protein; proline-rich protein BCA3; PKA-interacting protein; protein kinase A-interacting protein 1; breast cancer associated gene 3; C11orf17; A-kinase-interacting protein 1; OTTHUMP00000230630; OTTHUMP00000230631; OTTHUMP00000230632; OTTHUMP00000230634; OTTHUMP00000230635; OTTHUMP00000230637; OTTHUMP00000230638; OTTHUMP00000230639;
C9orf98
AK8 adenylate kinase 8
DDX31; C9orf98; FLJ32704; FLJ36014; RP11-143F18.1; adenylate kinase 8; OTTHUMP00000022737; putative adenylate kinase-like protein C9orf98;
SGK269
PEAK1 NKF3 kinase family member
SGK269; FLJ21140; FLJ34483; KIAA2002; pseudopodium-enriched atypical kinase 1; sugen kinase 269; tyrosine-protein kinase SgK269; pseudopodium enriched atypical kinase;
DSP
desmoplakin
DSP; desmoplakin; DP; DPI; DPII; desmoplakin I; desmoplakin II; 250/210 kDa paraneoplastic pemphigus antigen;
EVPL
envoplakin
EVPL; envoplakin; EVPK; 210 kDa cornified envelope; 210 kDa paraneoplastic pemphigus antigen; p210; 210 kDa cornified envelope precursor protein;
NKD2
naked cuticle homolog 2 (Drosophila)
NKD2; naked cuticle homolog 2 (Drosophila); protein naked cuticle homolog 2; Dvl binding protein NKD2; naked cuticle 2; Naked2; hNkd2; Naked 2; naked-2; naked cuticle-2; OTTHUMP00000115406; OTTHUMP00000220490; Dvl-binding protein NKD2;
PKP1
plakophilin 1 (ectodermal dysplasia/skin fragility syndrome)
B6P; PKP1; MGC138829; Plakophilin 1;
KCNAB1
potassium voltage-gated channel, shaker-related subfamily, beta member 1
KCNAB1; potassium voltage-gated channel, shaker-related subfamily, beta member 1; voltage-gated potassium channel subunit beta-1; AKR6A3; hKvb3; hKvBeta3; KCNA1B; Kvb1.3; K(+) channel subunit beta-1; potassium channel beta 3 chain; potassium channel beta3;
KCNA2
potassium voltage-gated channel, shaker-related subfamily, member 2
KCNA2; potassium voltage-gated channel, shaker-related subfamily, member 2; potassium voltage-gated channel subfamily A member 2; HK4; Kv1.2; voltage-gated K(+) channel HuKIV; voltage-gated potassium channel HBK5; voltage-gated potassium channel protein K;
HRK
harakiri, BCL2 interacting protein (contains only BH3 domain)
HRK; DP5; HARAKIRI; harakiri, BCL2 interacting protein (contains only BH3 domain); activator of apoptosis hara-kiri; activator of apoptosis Hrk; Neuronal death protein DP5; BCL2-interacting protein; BH3-interacting domain-containing protein 3; death protein 5; harakiri, BCL2-interacting protein (contains only BH3 domain); BID3;
MICU1
mitochondrial calcium uptake 1
MICU1; mitochondrial calcium uptake 1; CALC; EFHA3; MPXPS; CBARA1; calcium uptake protein 1, mitochondrial; ara CALC; atopy-related autoantigen CALC; calcium-binding atopy-related autoantigen 1;
IP6K3
inositol hexakisphosphate kinase 3
IP6K3; inositol hexakisphosphate kinase 3; IHPK3, inositol hexaphosphate kinase 3; INSP6K3; InsP6 kinase 3; inositol hexaphosphate kinase 3; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase; IHPK3; MGC102928;
HPS3
Hermansky-Pudlak syndrome 3
HPS3; Hermansky-Pudlak syndrome 3; Hermansky-Pudlak syndrome 3 protein; SUTAL; Cocoa; DKFZp686F0413; FLJ22704; Hermansky Pudlak syndrome 3; Hermansky Pudlak syndrome 3 protein;
HPS4
Hermansky-Pudlak syndrome 4
HPS4; Hermansky-Pudlak syndrome 4; Hermansky-Pudlak syndrome 4 protein; KIAA1667; LE; Hermansky Pudlak syndrome 4 protein; Light ear protein homolog; light-ear protein homolog; bK1048E9.4; bK1048E9.5;
HPS5
Hermansky-Pudlak syndrome 5
HPS5; Hermansky-Pudlak syndrome 5; Hermansky-Pudlak syndrome 5 protein; ruby-eye protein 2 homolog; alpha integrin binding protein 63; alpha-integrin-binding protein 63; AIBP63; KIAA1017;
KAZN
kazrin, periplakin interacting protein
KAZN; kazrin, periplakin interacting protein; kazrin; FLJ43806; KIAA1026; HRIHFB2003; KAZ; KAZRN_HUMAN; RP1-21O18.1;
PPIP5K2
diphosphoinositol pentakisphosphate kinase 2
PPIP5K2; diphosphoinositol pentakisphosphate kinase 2; HISPPD1, histidine acid phosphatase domain containing 1; inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2; KIAA0433; VIP2; hsVIP2; VIP1 homolog 2; insP6 and PP-IP5 kinase 2;
PPIP5K1
diphosphoinositol pentakisphosphate kinase 1
PPIP5K1; diphosphoinositol pentakisphosphate kinase 1; HISPPD2A, histidine acid phosphatase domain containing 2A; inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1; IPS1; KIAA0377; VIP1; IP6K; Histidine acid phosphatase domain-containing protein 2A; hsVIP1; Inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinase 1; Inositol pyrophosphate synthase 1; InsP6 and PP IP5 kinase 1; IP6 kinase; PP IP5 kinase 1; VIP1 homolog; insP6 and PP-IP5 kinase 1; histidine acid phosphatase domain containing 2A; HISPPD2A;
HPS1
Hermansky-Pudlak syndrome 1
HPS1; Hermansky-Pudlak syndrome 1; Hermansky Pudlak syndrome , HPS; Hermansky-Pudlak syndrome 1 protein; Hermansky Pudlak syndrome 1 protein; Hermansky Pudlak syndrome gene; Hermansky Pudlak syndrome type 1; HPS; MGC5277; Hermansky-Pudlak syndrome type 1;
HPS6
Hermansky-Pudlak syndrome 6
HPS6; Hermansky-Pudlak syndrome 6; Hermansky-Pudlak syndrome 6 protein; FLJ22501; Hermansky Pudlak syndrome 6 protein; MGC20522; Ru; Ruby eye protein homolog; ruby-eye protein homolog; Hermansky-Pudlak syndrome-6 protein (HPS6); RP11-302K17.1;
IP6K1
inositol hexakisphosphate kinase 1
IP6K1; inositol hexakisphosphate kinase 1; IHPK1, inositol hexaphosphate kinase 1; KIAA0263; IHPK1; Inositol hexaphosphate kinase 1; InsP6; InsP6 kinase 1; Itpk6; PiUS; Pi uptake stimulator; ATP:1D-myo-inositol-hexakisphosphate phosphotransferase;
IPPK
inositol 1,3,4,5,6-pentakisphosphate 2-kinase
IPPK; inositol 1,3,4,5,6-pentakisphosphate 2-kinase; C9orf12, chromosome 9 open reading frame 12; inositol-pentakisphosphate 2-kinase; FLJ13163; INSP5K2; IP5K; IPK1; 3; 4; 5; 6)P5 2-kinase; 6-pentakisphosphate 2-kinase; bA476B13.1 (novel protein); C9orf12; inositol 1,3,4,5,6 pentakisphosphate 2 kinase; Inositol pentakisphosphate 2 kinase; Inositol-1; Ins; Ins(1; InsP5 2 kinase; InsP5 2-kinase; IPK1 homolog; IPPK_HUMAN; ins(1,3,4,5,6)P5 2-kinase; bA476B13.1;
KCNA5
potassium voltage-gated channel, shaker-related subfamily, member 5
KCNA5; potassium voltage-gated channel, shaker-related subfamily, member 5; potassium voltage-gated channel subfamily A member 5; HK2; HPCN1; Kv1.5; potassium channel 1; cardiac potassium channel; potassium channel protein; voltage-gated potassium channel;
KCNA7
potassium voltage-gated channel, shaker-related subfamily, member 7
KCNA7; potassium voltage-gated channel, shaker-related subfamily, member 7; potassium voltage-gated channel subfamily A member 7; HAK 6; HAK6; KCNA 7; KCNA7_HUMAN; KV1.7; Potassium voltage gated channel shaker related subfamily member 7; Potassium voltage gated channel subfamily A member 7; Voltage dependent potassium channel Kv1.7; Voltage gated potassium channel KCNA7; Voltage gated potassium channel subunit Kv1.7; Voltage-gated potassium channel subunit Kv1.7; potassium voltage gated channel, shaker related subfamily, member 7;
KCNA10
potassium voltage-gated channel, shaker-related subfamily, member 10
KCNA10; potassium voltage-gated channel, shaker-related subfamily, member 10; potassium voltage-gated channel subfamily A member 10; Kv1.8; cyclic GMP gated potassium channel; voltage-gated potassium channel subunit Kv1.8; Kcn1;
NBPF7
neuroblastoma breakpoint family, member 7
NBPF7; neuroblastoma breakpoint family, member 7; putative neuroblastoma breakpoint family member 7; LOC343505; NBPF 7;
NBPF8
neuroblastoma breakpoint family, member 8
NBPF8; neuroblastoma breakpoint family, member 8; hypothetical protein LOC728841; Neuroblastoma breakpoint family member 8; NBPF11; NBPF21;
MAK16
MAK16 homolog (S. cerevisiae)
MAK16; MAK16 homolog (S. cerevisiae); RBM13, RNA binding motif protein 13; protein MAK16 homolog; MAK16L; MAK16 homolog; NNP78; Protein RBM13; RBM13; RNA binding motif protein 13; RNA binding protein;
MKL1
megakaryoblastic leukemia (translocation) 1
MKL1; megakaryoblastic leukemia (translocation) 1; MKL/myocardin-like protein 1; basic; SAP and coiled coil domain; BSAC; KIAA1438; MAL; megakaryocytic acute leukemia; MRTF A; myocardin related transcription factor A; basic, SAP and coiled-coil domain; me;
NKD1
naked cuticle homolog 1 (Drosophila)
NKD1; naked cuticle homolog 1 (Drosophila); protein naked cuticle homolog 1; Dvl-binding protein; naked cuticle 1 homolog; Naked-1; NKD; naked cuticle-1; Naked1;
PAK1IP1
PAK1 interacting protein 1
PAK1IP1; PAK1 interacting protein 1; p21-activated protein kinase-interacting protein 1; bA421M1.5; FLJ20624; hPIP1; MAK11; PIP1; WDR84; hPIP 1; MAK 11; p21 activated protein kinase interacting protein 1; PAK/PLC interacting protein 1; PAK1 interacting protein; PIP 1; RP11 421M1.5; WD repeat containing protein 84; WDR 84; PAK1-interacting protein 1; PAK/PLC-interacting protein 1; WD repeat-containing protein 84; RP11-421M1.5;
PPL
Periplakin
PPL; periplakin; 190 kDa paraneoplastic pemphigus antigen; 195 kDa cornified envelope precursor protein; KIAA0568; MGC134872; OTTHUMP00000159922;
SSX5
synovial sarcoma, X breakpoint 5
SSX5; synovial sarcoma, X breakpoint 5; protein SSX5; SSX5_HUMAN;
SSX2IP
synovial sarcoma, X breakpoint 2 interacting protein
SSX2IP; synovial sarcoma, X breakpoint 2 interacting protein; afadin- and alpha-actinin-binding protein; SSX2-interacting protein; afadin DIL domain-interacting protein; ADIP; FLJ10848; KIAA0923; MGC75026;
SSX4B
synovial sarcoma, X breakpoint 4B
SSX4B; synovial sarcoma, X breakpoint 4B; protein SSX4; OTTHUMT00000056510; Cancer/testis antigen 5.4; CT5.4; MGC119056; MGC12411; MGC169015; MGC169016; SSX4; SSX4A; Synovial sarcoma X breakpoint 4; Synovial sarcoma X breakpoint 4B;
NALCN
sodium leak channel, non-selective
NALCN; sodium leak channel, non-selective; VGCNL1, voltage gated channel like 1; sodium leak channel non-selective protein; bA430M15.1; CanIon; voltage gated channel like 1; voltage gated channel-like protein 1; four repeat voltage-gated ion channel; VGC;
UPK1A
uroplakin 1A
UPK1A; uroplakin 1A; uroplakin-1a; TSPAN21; UP1A; UPIA; UPKA; tspan-21; uroplakin Ia; tetraspanin-21;
UPK3B
uroplakin 3B
UPK3B; uroplakin 3B; uroplakin-3b; FLJ32198; MGC10902; p35; UPIIIb; uroplakin IIIb; UP3b; UPK3B_HUMAN;
KCNA6
potassium voltage-gated channel, shaker-related subfamily, member 6
KCNA6; potassium voltage-gated channel, shaker-related subfamily, member 6; HBK2; KV1.6; potassium voltage-gated channel subfamily A member 6; human brain potassium channel-2; voltage-gated potassium channel HBK2; voltage-gated potassium channel protein Kv1.6; voltage-gated potassium channel subunit Kv1.6;
KCNAB2
potassium voltage-gated channel, shaker-related subfamily, beta member 2
KCNAB2; potassium voltage-gated channel, shaker-related subfamily, beta member 2; voltage-gated potassium channel subunit beta-2; AKR6A5; HKvbeta2.1; HKvbeta2.2; KCNA2B; K+ channel beta-2 subunit; K(+) channel subunit beta-2; potassium channel shaker chai;
KCNA4
potassium voltage-gated channel, shaker-related subfamily, member 4
KCNA4; potassium voltage-gated channel, shaker-related subfamily, member 4; KCNA4L, potassium voltage gated channel, shaker related subfamily, member 4 like; potassium voltage-gated channel subfamily A member 4; HK1; HPCN2; Kv1.4; potassium channel 2; ty;
Tcl1
T cell lymphoma breakpoint 1
TCL1;T cell lymphoma breakpoint 1;ENSMUSG00000041359;Tcl1a;12 E;12 52.0 cM;T-cell leukemia/lymphoma protein 1A;T-cell leukemia/lymphoma protein 1A;TCL-1;oncogene TCL1;oncogene TCL-1;protein p14 TCL1;T-cell lymphoma breakpoint 1;
EVPLL
envoplakin-like
EVPLL;envoplakin-like;35236;ENSG00000214860;17p11.2;envoplakin-like protein;envoplakin-like protein;
Bfsp2
beaded filament structural protein 2, phakinin
BFSP2; beaded filament structural protein 2, phakinin; CP47; CP49; LIFL-L; Phakinin; 49 kDa cytoskeletal protein; beaded filament protein CP49; bfps2, Cytoskeletal protein, 49-kD; lens intermediate filament-like light; lens fiber cell beaded filament protein CP 47; lens fiber cell beaded filament protein CP 49; MGC142078; MGC142080; OTTHUMP00000216298; PHAKOSIN;
Sphkap
SPHK1 interactor, AKAP domain containing
Sphkap; Skip; RGD1311951; A-kinase anchor protein SPHKAP; sphingosine kinase type 1-interacting protein; SPHK1-interactor and AKAP domain-containing protein;
Nppb-releasing TRPV1 “Takes Charge of” Itch Transmitting
TRPV1 cells, sensory neurons, have long been known that can detect itchy substances as well as other sensations, such as hot and pain, on the skin. But more specifically, it is unclear whether the neurons are unique responding to itch. In order to find answers, researchers did relevant exper...
Angewandte Chemie: The New Method to Make Therapeutic Proteins Last Longer
Nowadays therapeutic proteins are widely used to relieve sufferers from many conditions, such as cancers (Monoclonal antibodies, Interferons), heart disease and stroke (Enzymes, Blood factors), diabetes (Insulin), anaemia (Erythropoietin), haemophilia (Blood clotting factors) etc. and they show pr...
What Makes a Good Corporation--On Creative BioMart’s Last Week-Meeting
Creative BioMart, a world leading biotech company that has served thousands of customers all over the world in the biotech field including the supply of recombinant proteins, antigens, as well as a wide range of services, last day launched its 64th week-meeting. Week-meeting is aranged every Wednesd...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
What is IRAK2 Protein
See All IRAK2 Products The IRAK2 protein, formally known as Interleukin-1 receptor-associated kinase 2, is a pivotal player in cellular signaling pathways. It goes by various synonyms, including IRAK-2 and Pelle-like protein kinase. Belonging to the IRAK family, IRAK2 is a kinase, a type of enzyme t...
What is PAK4 Protein
See All PAK4 Products The PAK4 protein, officially known as p21-activated kinase 4, belongs to the family of p21-activated kinases (PAKs). It is also referred to by synonyms such as PAK4, PAKγ, and PAKB. PAK4 is a serine/threonine protein kinase that plays a crucial role in various cellular processe...
What is IRAK4 Protein?
See All IRAK4 Products The Interleukin-1 receptor-associated kinases or IRAK protein is an integral part of the immune response in many life forms. Among these proteins lies IRAK4, which plays a crucial role in the immune response system. Understanding IRAK4 isn't just about understanding the immuni...
JAK-STAT Signal Pathway
JAK-STAT signal pathway is a cytokine-stimulated signal transduction pathway found in recent years. It is involved in many important biological processes such as cell proliferation, differentiation, apoptosis and immune regulation. Compared with other signaling, the JAK-STAT signal pathway is re...
